RON Clocks Five-Year Cancer Survival in Portugal at 66% for the 2019 Cohort — Women Sit 10 Points Above Men, Thyroid and Testicular Tumours Clear 90% and Madeira Trails the Mainland
RON pegs five-year cancer survival in Portugal at 66% for the 2019 cohort — women hold a 10-point edge over men, thyroid and testicular tumours clear 90%, and Madeira trails the mainland on outcomes.